Skip to content

Radio-frequency sensing: non-invasive monitoring of heart failure progression

Radio-frequency sensing: non-invasive monitoring of heart failure progression - AIM-HF study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56751
Enrollment
50
Registered
2023-09-04
Start date
2024-03-11
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decompensation, heart failure

Interventions

Participants undergo the following measurements, outside of standard care: - TTE and RF Sensing measurement. - MRI and RF Sensing measurement. - RF Sensing measurement during catheterization (only if

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients planned for a right heart catheterization with invasive pressure measurement • Patients that are screened for a left ventricular assist device or a heart transplant • Patients that have recently received a heart transplant • Patients with NYHA class II-IV heart failure, preserved as well as reduced ejection fraction • Patients with pulmonary hypertension • Patients with known (risk of) chemotherapy induced cardiac dysfunction • Patients with any cardiac arrhythmia • Patients with an implantable pulmonary artery pressure sensor •Cardiovascular patients on the intensive care unit or cardiac care unit undergoing daily hemodynamic measurements

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Patients that have an active implant (cardiac implant such as CRT, ICD, LVAD, or any other active implants such as insulin pump, cochlear implant or neural stimulator) that cannot be switched to passive or sensing mode. • Patients is expected to die within 6 months from any nonrelated disease • Patient that are not physically able to undergo TTE, MRI and/or RFS measurements at the time of inclusion

Design outcomes

Primary

MeasureTime frame
Primary endpoint 1: correlation between RFS parameters and non-invasive hemodynamic parameters in cardiovascular patients. • Key parameters RFS: signal amplitude, area under the curve, average value, frequency, spectral content • Key parameters non-invasive hemodynamic measurements: estimated left ventricular end diastolic pressure, left ventricular ejection fraction, left ventricular stroke volume, right ventricular ejection fraction, right ventricular stroke volume

Secondary

MeasureTime frame
Secondary endpoint 1: correlation between RFS parameters and non-invasive hemodynamic parameters in cardiovascular patients. • Key parameters RFS: signal amplitude, area under the curve, average value, frequency, spectral content • Key parameters invasive hemodynamic measurements: atrial pressure, right ventricular pressure, pulmonary capillary wedge pressure and pulmonary artery pressure, diastolic/systolic/mean Secondary endpoint 2: Difference in RFS parameters in cardiovascular patients before and after treatment • Key parameters RFS: signal amplitude,area under the curve value, average value, frequency

Countries

Netherlands

Contacts

Public ContactBR Steensma

Universitair Medisch Centrum Utrecht

m.wosten-2@umcutrecht.nl0887555555

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)